Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. [electronic resource]
Producer: 20100603Description: 429-36 p. digitalISSN:- 1476-5365
- Adolescent
- Adult
- Antilymphocyte Serum -- administration & dosage
- Child
- Female
- Hematologic Neoplasms -- therapy
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Infections -- etiology
- Leukemia, Myeloid, Acute -- therapy
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Myeloablative Agonists -- administration & dosage
- Myelodysplastic Syndromes -- therapy
- Survival Rate
- T-Lymphocytes -- immunology
- Thiotepa -- administration & dosage
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Treatment Outcome
- Vidarabine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.